The changing epidemiology of vancomycin-resistant enterococci

Infection Control and Hospital Epidemiology

Volumn 24, Issue 4, 2003, Pages 264-268

  Lai, Kwan Kew ^a   Fontecchio, Sally A ^b   Kelley, Anita L ^b   Baker, Stephen ^a   Melvin, Zita S ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CARRIER; BACTERIUM CULTURE; ENTEROCOCCUS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; PREVALENCE; RECTUM; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CROSS INFECTION; ENTEROCOCCUS; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; RECTUM; VANCOMYCIN RESISTANCE;

EID: 0038071645     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502203     Document Type: Article

References (21)

1. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-161.
2. Uttley AHC, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infection. Epidemiol Infect 1989;103:173-181.
3. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239-249.
4. Martone WJ. Vancomycin-resistant enterococci: an update. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA.
5. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001:344;1427-1433.
6. Trick WE, Kuehnert MJ, Quirk SB, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999;180:391-396.
7. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grew Aerobically, 3rd ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.
8. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.
9. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolen RH, eds. Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society of Microbiology; 1995:1327-1341.
10. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol 1993;31:1609-1611.
11. Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin resistant Staphylococcus aureus. Am J Med 1991;91(suppl 3B):233S-237S.
12. Jarvis WR, Thornsberry C, Boyce J, Hughes JM. Methicillin-resistant Staphylococcus aureus at children's hospitals in the United States. Pediatr Infect Dis 1985;4:651-655.
13. Boyce JM, Causey WA. Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 1982;3:377-383.
14. Lai KK, Fontecchio SA, Kelley AL, Melvin ZS. The epidemiology of fecal carriage of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1997;18:762-765.
15. Linden P, Pasculle AW, Kramer DJ, Kusne S, Manez R. The duration of fecal carriage of vancomycin-resistant Enterococcus faecium (VREF). Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; October 4-7, 1994; Orlando, FL. Abstract J150.
16. Polish L, Hebden J, Shay D, Jarvis W, Schwalbe R, Morris JG Jr. Duration of fecal carriage of vancomycin-resistant enterococcus (VRE) in ICU patients. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA. Abstract J37.
17. Henning K, Boone JN, Brown AK, Wollner N, DeLencastre H, Armstrong D. Stool surveillance for vancomycin-resistant Enterococcus faecium (VREF) on a pediatric oncology ward: duration of shedding and incidence of clinical infections. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1995; San Francisco, CA. Abstract J38.
18. Montecalvo MA, de Lencastre H, Carraher M, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-685.
19. Bonten MJM, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127-1132.
20. Morris JG Jr, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann intern Med 1995;123:250-259.
21. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925-1932.